Changfeng Pharmaceuticals (02652.HK) has completed the placement of 21,747,700 new H shares, raising approximately HKD 295 million.

Zhuhong Finance APP reported that Changfeng Pharmaceutical (02652.HK) announced the completion of the placement of 21,747,700 new H shares on August 6, 2026, at a placement price of HKD 13.82 per H share, raising approximately HKD 295 million net.